Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study

• Egile Nagusiak: Hsien-Yi Chiu (Egilea), Rosaline Chung-Yee Hui (Egilea), Yu-Huei Huang (Egilea), Ruey-Yun Huang (Egilea), Kai-Lung Chen (Egilea), Ya-Chu Tsai (Egilea), Po-Ju Lai (Egilea), Ting-Shun Wang (Egilea), Tsen-Fang Tsai (Egilea)
• Formatua: Liburua
• Argitaratua: Medical Journals Sweden, 2018-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Safety data for secukinumab in patients with psoriasis and viral hepatitis are lacking. The aim of this study is to investigate the risk of reactivation of hepatitis B virus (HBV)/hepatitis C virus (HCV) in patients with psoriasis who are receiving secukinumab therapy. This multicentre study screene...